annual current liabilities:
$1.04B-$498.12M(-32.42%)Summary
- As of today (May 21, 2025), JAZZ annual total current liabilities is $1.04 billion, with the most recent change of -$498.12 million (-32.42%) on December 31, 2024.
- During the last 3 years, JAZZ annual current liabilities has risen by +$229.27 million (+28.33%).
- JAZZ annual current liabilities is now -32.42% below its all-time high of $1.54 billion, reached on December 31, 2023.
Performance
JAZZ Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$1.22B+$184.04M(+17.72%)Summary
- As of today (May 21, 2025), JAZZ quarterly total current liabilities is $1.22 billion, with the most recent change of +$184.04 million (+17.72%) on March 1, 2025.
- Over the past year, JAZZ quarterly current liabilities has dropped by -$339.60 million (-21.74%).
- JAZZ quarterly current liabilities is now -22.29% below its all-time high of $1.57 billion, reached on September 30, 2023.
Performance
JAZZ quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
JAZZ Current liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -32.4% | -21.7% |
3 y3 years | +28.3% | +65.8% |
5 y5 years | +184.9% | +208.6% |
JAZZ Current liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -32.4% | +28.3% | -22.3% | +73.3% |
5 y | 5-year | -32.4% | +184.9% | -22.3% | +208.6% |
alltime | all time | -32.4% | +4350.5% | -22.3% | +5720.6% |
JAZZ Current liabilities History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $1.22B(+17.7%) |
Dec 2024 | $1.04B(-32.4%) | $1.04B(+0.8%) |
Sep 2024 | - | $1.03B(-33.8%) |
Jun 2024 | - | $1.56B(-0.4%) |
Mar 2024 | - | $1.56B(+1.7%) |
Dec 2023 | $1.54B(+64.7%) | $1.54B(-2.3%) |
Sep 2023 | - | $1.57B(+66.4%) |
Jun 2023 | - | $945.26M(+4.0%) |
Mar 2023 | - | $908.90M(-2.6%) |
Dec 2022 | $933.19M(+15.3%) | $933.19M(+14.8%) |
Sep 2022 | - | $812.95M(+15.2%) |
Jun 2022 | - | $705.44M(-4.3%) |
Mar 2022 | - | $737.41M(-8.9%) |
Dec 2021 | $809.30M(+23.8%) | $809.30M(+10.1%) |
Sep 2021 | - | $735.05M(-16.5%) |
Jun 2021 | - | $880.59M(+17.1%) |
Mar 2021 | - | $752.09M(+15.0%) |
Dec 2020 | $653.75M(+79.4%) | $653.75M(+1.8%) |
Sep 2020 | - | $642.13M(+56.6%) |
Jun 2020 | - | $409.96M(+3.5%) |
Mar 2020 | - | $396.12M(+8.7%) |
Dec 2019 | $364.49M(+5.5%) | $364.49M(-6.6%) |
Sep 2019 | - | $390.44M(+5.7%) |
Jun 2019 | - | $369.49M(-10.8%) |
Mar 2019 | - | $414.00M(+19.8%) |
Dec 2018 | $345.49M(+17.5%) | $345.49M(+1.2%) |
Sep 2018 | - | $341.29M(-1.9%) |
Jun 2018 | - | $347.95M(-7.4%) |
Mar 2018 | - | $375.62M(+27.8%) |
Dec 2017 | $293.95M(+14.2%) | $293.95M(+9.6%) |
Sep 2017 | - | $268.18M(+7.1%) |
Jun 2017 | - | $250.39M(-36.2%) |
Mar 2017 | - | $392.77M(+52.6%) |
Dec 2016 | $257.41M(+13.6%) | $257.41M(+10.5%) |
Sep 2016 | - | $232.86M(+2.7%) |
Jun 2016 | - | $226.72M(-43.2%) |
Mar 2016 | - | $398.83M(+76.0%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2015 | $226.64M(+4.5%) | $226.64M(-33.4%) |
Sep 2015 | - | $340.19M(+51.1%) |
Jun 2015 | - | $225.16M(+2.1%) |
Mar 2015 | - | $220.58M(+1.7%) |
Dec 2014 | $216.80M(+6.3%) | $216.80M(-3.1%) |
Sep 2014 | - | $223.74M(+13.1%) |
Jun 2014 | - | $197.77M(-16.9%) |
Mar 2014 | - | $238.01M(+16.7%) |
Dec 2013 | $204.03M(+6.5%) | $204.03M(+0.3%) |
Sep 2013 | - | $203.36M(+10.3%) |
Jun 2013 | - | $184.35M(-24.4%) |
Mar 2013 | - | $243.72M(+27.2%) |
Dec 2012 | $191.54M(+262.3%) | $191.54M(+7.3%) |
Sep 2012 | - | $178.57M(-7.1%) |
Jun 2012 | - | $192.32M(+83.9%) |
Mar 2012 | - | $104.58M(+97.8%) |
Dec 2011 | $52.87M(-11.8%) | $52.87M(-8.1%) |
Sep 2011 | - | $57.53M(-29.2%) |
Jun 2011 | - | $81.32M(+32.3%) |
Mar 2011 | - | $61.44M(+2.5%) |
Dec 2010 | $59.94M(+1.2%) | $59.94M(+6.5%) |
Jun 2010 | - | $56.28M(-19.5%) |
Mar 2010 | - | $69.91M(+18.0%) |
Dec 2009 | $59.24M(-65.9%) | $59.24M(+55.4%) |
Sep 2009 | - | $38.11M(-24.1%) |
Jun 2009 | - | $50.21M(-70.2%) |
Mar 2009 | - | $168.53M(-2.9%) |
Dec 2008 | $173.49M(+370.7%) | $173.49M(+161.1%) |
Sep 2008 | - | $66.44M(-5.5%) |
Jun 2008 | - | $70.30M(-5.9%) |
Mar 2008 | - | $74.72M(+102.7%) |
Dec 2007 | $36.86M(+20.8%) | $36.86M(+17.5%) |
Sep 2007 | - | $31.36M(-0.8%) |
Jun 2007 | - | $31.63M(+50.6%) |
Mar 2007 | - | $21.00M(-31.2%) |
Dec 2006 | $30.52M(+30.8%) | $30.52M(+30.8%) |
Dec 2005 | $23.34M | $23.34M |
FAQ
- What is Jazz Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals annual current liabilities year-on-year change?
- What is Jazz Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly current liabilities year-on-year change?
What is Jazz Pharmaceuticals annual total current liabilities?
The current annual current liabilities of JAZZ is $1.04B
What is the all time high annual current liabilities for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual total current liabilities is $1.54B
What is Jazz Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, JAZZ annual total current liabilities has changed by -$498.12M (-32.42%)
What is Jazz Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of JAZZ is $1.22B
What is the all time high quarterly current liabilities for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly total current liabilities is $1.57B
What is Jazz Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, JAZZ quarterly total current liabilities has changed by -$339.60M (-21.74%)